Clinical-stage company with a transdermal drug-delivery patch (TEPI Patch).
| Date | Round | Amount |
|---|---|---|
| Apr 2023 | Funding round UK clinical-stage company Medherant raised £2.9M led by Mercia Asset Management for its testosterone patch. | $3.6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.